J.L. Pellegrin - Concepedia

Author

J.L. Pellegrin

Also Known As

C Rivoisy, C Tumiotto, C. Tumiotto, E Lazaro, G Morissonneau, J -L Pellegrin, J L Pellegrin, J PELLEGRIN, J Pellegrin, J. L. Pellegrin

100

Publications

857

Citations

H-Index

Concepts

All Affiliations

Inserm Hôpital Cardiologique du Haut-Lévêque Hôpital Saint-André Bordeaux Population Health Université de Bordeaux

About

J.L. Pellegrin is an author at Inserm specializing in medicine, hiv, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	206
2	Public Health	3	3	96
3	Health Sciences	2	2	77
4	Biochemistry	1	1	13
5	Cell Biology	1	1	13

J.L. Pellegrin

Publications

548

Citations

H-Index

Page 1

	Year	Citations
Role of Uncontrolled HIV RNA Level and Immunodeficiency in the Occurrence of Malignancy in HIV‐Infected Patients during the Combination Antiretroviral Therapy Era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort Mathias Bruyand, Rodolphe Thiébaut, S. Lawson‐Ayayi, Clinical Infectious Diseases	2009	115
Soluble Adhesion Molecules and Endothelial Cell Damage in HIV Infected Patients M. Seigneur, J. Constans, Andrew D. Blann, Thrombosis and Haemostasis	1997	96
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies Pierre Frange, Lambert Assoumou, Diane Descamps, Journal of Antimicrobial Chemotherapy Phi PatientsImmunodeficienciesFirst-line StrategiesDrug ResistanceHuman Retrovirus	2015	44
Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400 × 106 cells/l Rodolphe Thiébaut, Isabelle Pellegrin, Geneviève Chêne, AIDS	2004	42
Simultaneous determination of ritonavir and saquinavir, two human immunodeficiency virus protease inhibitors, in human serum by high-performance liquid chromatography Soriana Frappier, Dominique Breilh, E Diarte, Journal of Chromatography B Biomedical Sciences and Applications Antiviral CompoundMedicineBioanalysisAntiviral Drug DevelopmentAntiviral Therapy	1998	42
In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients J. Maugein, J.L. Pellegrin, G. Brossard, Antimicrobial Agents and Chemotherapy Neutropenic PatientsHealth SciencesAntibioticsCoagulase-negative StaphylococciMedicine	1990	42
One-Year Antioxidant Supplementation with -Carotene or Selenium for Patients Infected with Human Immunodeficiency Virus: A Pilot Study J. Constans, Marie‐Christine Delmas‐Beauvieux, Claire Sergeant, Clinical Infectious Diseases NutritionSelenium DeficiencyOne-year Antioxidant SupplementationHivHuman Immunodeficiency Virus	1996	36
Fatty acids and plasma antioxidants in HIV-positive patients: Correlation with nutritional and immunological status J. Constans, E. Peuchant, J.L. Pellegrin, Clinical Biochemistry Metabolic SyndromeNutritionFatty AcidsOmega-3 Fatty AcidGlobal Health	1995	35
Diabetes and cognitive decline in a French cohort of patients infected with HIV-1 Carole Dufouil, Laura Richert, Rodolphe Thiébaut, Neurology	2015	27
The DAD Study Group. Combination antiretroviral therapy and the risk of myocardial infarction Nina Friis‐Møller, Caroline Sabin, Reinhold Weber, Hiv/aids CounsellingCardiovascular DiseaseTreatment And PreventionCombination Antiretroviral TherapyAntiviral Therapy	2003	17

Page 1